Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
14.01
-0.17 (-1.20%)
At close: Jun 26, 2026, 4:00 PM EDT
14.18
+0.17 (1.21%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Summit Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $18 | Hold | Maintains | $18 | +28.48% | Jun 2, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $45 | Buy | Maintains | $45 | +221.20% | Jun 1, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $40 | Buy | Maintains | $40 | +185.51% | Jun 1, 2026 |
| Citi | Citi | Buy Maintains $40 | Buy | Maintains | $40 | +185.51% | Jun 1, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $30 | Buy | Reiterates | $30 | +114.13% | Jun 1, 2026 |
| Bernstein | Bernstein | Sell Reiterates $7.7 | Sell | Reiterates | $7.7 | -45.04% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 1, 2026 |
| Jefferies | Jefferies | Hold Maintains $17 | Hold | Maintains | $17 | +21.34% | May 21, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.